(株)カワチ薬品の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 2664/E03356 | CAWACHI LIMITED |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/02/25 | 日証協 | 692,530株 | +77.84% | 453,610株 | +257.71% | 1,658,089株 | +66.45% | 792,064株 | +285.66% |
2022/02/18 | 日証協 | 389,419株 | +18.76% | 126,811株 | +1.53% | 996,146株 | +18.42% | 205,379株 | +85.11% |
2022/02/10 | 日証協 | 327,896株 | +43.64% | 124,900株 | +222.74% | 841,213株 | +5.74% | 110,949株 | +89.31% |
2022/02/04 | 日証協 | 228,283株 | -1.25% | 38,700株 | +294.9% | 795,516株 | -2.6% | 58,606株 | -69.01% |
2022/01/28 | 日証協 | 231,183株 | -0.81% | 9,800株 | -46.51% | 816,730株 | +21.97% | 189,115株 | +199.61% |
2022/01/21 | 日証協 | 233,071株 | -5.25% | 18,320株 | -54.75% | 669,608株 | +0.92% | 63,120株 | -13.18% |
2022/01/14 | 日証協 | 245,996株 | -11% | 40,488株 | +65.43% | 663,498株 | +3.9% | 72,700株 | +40.89% |
2022/01/07 | 日証協 | 276,408株 | -4.12% | 24,475株 | -64.18% | 638,598株 | +1.48% | 51,602株 | +45.52% |
2021/12/30 | 日証協 | 288,299株 | 0% | 68,334株 | 0% | 629,302株 | 0% | 35,461株 | 0% |
2021/12/24 | 日証協 | 288,299株 | +27.93% | 68,334株 | +9.86% | 629,302株 | +2.94% | 35,461株 | -7.8% |
2021/12/17 | 日証協 | 225,365株 | +23.59% | 62,200株 | +432.81% | 611,305株 | -1.39% | 38,463株 | +45.98% |
2021/12/10 | 日証協 | 182,349株 | -0.29% | 11,674株 | -67.55% | 619,893株 | +0.89% | 26,348株 | -9.02% |
2021/12/03 | 日証協 | 182,871株 | +11.67% | 35,980株 | +141.12% | 614,430株 | +0.16% | 28,961株 | +35.33% |
2021/11/26 | 日証協 | 163,765株 | +2.68% | 14,922株 | +87.84% | 613,422株 | +79.35% | 21,400株 | -92.62% |
2021/11/19 | 日証協 | 159,487株 | +0.9% | 7,944株 | -55.98% | 342,021株 | +3.19% | 289,801株 | +810.38% |
2021/11/05 | 日証協 | 177,199株 | +6.68% | 27,481株 | -47.73% | 343,433株 | +0.98% | 84,550株 | +1.43% |
2021/10/29 | 日証協 | 166,099株 | +13.3% | 52,573株 | +620.77% | 340,111株 | +4.55% | 83,358株 | +58.38% |
2021/10/22 | 日証協 | 146,605株 | -21.48% | 7,294株 | +231.55% | 325,296株 | -8.24% | 52,630株 | +17.65% |
2021/10/15 | 日証協 | 186,705株 | -23.92% | 2,200株 | -91.37% | 354,491株 | +1.46% | 44,735株 | +80.78% |
※株式分割は考慮していませんのでご注意ください。
Page Top